World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02485002
Date of registration: 24/06/2015
Prospective Registration: No
Primary sponsor: Selcuk University
Public title: Differences in Urine NGAL Levels in Patients Undergoing RIRS With or Without Ureteral Access Sheath
Scientific title: Differences in Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels in Patients Undergoing Retrograde Intrarenal Surgery (RIRS) With or Without Ureteral Access Sheath (UAS)
Date of first enrolment: June 2015
Target sample size: 60
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02485002
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Turkey
Contacts
Name:     Ozcan Kilic, M.D.
Address: 
Telephone:
Email:
Affiliation:  Selcuk University, School of Medicine, Department of Urology
Key inclusion & exclusion criteria

Inclusion Criteria:

- Being between 18-65 years old

- Having an indication of retrograde infrarenal surgery (RIRS) due to kidney stone

Exclusion Criteria:

- Patients with uncontrolled diabetes mellitus and diabetic nephropathy

- Patients with blood pressure > 140/80 mmHg despite regular use of antihypertensive
agent(s)

- Patients with chronic kidney failure who need dialysis

- Patients who have had prerenal, renal or postrenal acute kidney failure 3 months or
much earlier

- Patients who have had pyelonephritis 3 months or much earlier

- Patients younger than 18 years or older than 65 years

- Patients who have undergone a kidney surgery within the last 3 months and have
abnormal kidney function tests

- Patients with a concomitant ureter stone who will undergo an endoscopic ureter stone
treatment at the same session



Age minimum: 18 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
Urolithiasis
Intervention(s)
Device: RIRS with ureteral access sheath
Device: RIRS without ureteral access sheath
Primary Outcome(s)
Urine NGAL level (ng/mL) [Time Frame: Within the first 7 days after surgery (RIRS)]
Secondary Outcome(s)
Blood urea level (mg/dL) and creatinine level (mg/dL) [Time Frame: Within the first 7 days after surgery (RIRS)]
Secondary ID(s)
SU-RIRS-UAS-02
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history